DE60322570D1 - Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung - Google Patents
Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendungInfo
- Publication number
- DE60322570D1 DE60322570D1 DE60322570T DE60322570T DE60322570D1 DE 60322570 D1 DE60322570 D1 DE 60322570D1 DE 60322570 T DE60322570 T DE 60322570T DE 60322570 T DE60322570 T DE 60322570T DE 60322570 D1 DE60322570 D1 DE 60322570D1
- Authority
- DE
- Germany
- Prior art keywords
- lactobacillus
- strains
- selection
- selecting
- breast milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 239000004615 ingredient Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000186606 Lactobacillus gasseri Species 0.000 abstract 2
- 210000004381 amniotic fluid Anatomy 0.000 abstract 2
- 210000004251 human milk Anatomy 0.000 abstract 2
- 235000020256 human milk Nutrition 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract 1
- 241000186842 Lactobacillus coryniformis Species 0.000 abstract 1
- 241000186840 Lactobacillus fermentum Species 0.000 abstract 1
- 241000186869 Lactobacillus salivarius Species 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 229940012969 lactobacillus fermentum Drugs 0.000 abstract 1
- 230000000626 neurodegenerative effect Effects 0.000 abstract 1
- 230000001703 neuroimmune Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP02/07169 | 2002-06-28 | ||
PCT/EP2003/006752 WO2004003235A2 (en) | 2002-06-28 | 2003-06-26 | Probiotic strains, a process for the selection of them, compositions thereof, and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60322570D1 true DE60322570D1 (de) | 2008-09-11 |
Family
ID=29797105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60322570T Expired - Lifetime DE60322570D1 (de) | 2002-06-28 | 2003-06-26 | Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung |
Country Status (13)
Country | Link |
---|---|
US (2) | US20040057943A1 (de) |
EP (1) | EP1565547B2 (de) |
JP (1) | JP4176715B2 (de) |
AT (1) | ATE402993T1 (de) |
AU (1) | AU2003242763B2 (de) |
CA (1) | CA2490016C (de) |
DE (1) | DE60322570D1 (de) |
DK (1) | DK1565547T4 (de) |
ES (1) | ES2311729T5 (de) |
NZ (1) | NZ537706A (de) |
PT (1) | PT1565547E (de) |
SI (1) | SI1565547T2 (de) |
WO (1) | WO2004003235A2 (de) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
US20040265279A1 (en) * | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
CN102319417B (zh) * | 2003-10-13 | 2014-08-13 | 雀巢技术公司 | 减轻内毒素的效应 |
EP1689417A2 (de) * | 2003-10-13 | 2006-08-16 | Nestec S.A. | Abswächung der wirkung von endotoxinen |
US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
JP4589618B2 (ja) * | 2003-11-28 | 2010-12-01 | 独立行政法人農業生物資源研究所 | 免疫調節性機能を誘導する乳酸菌類とその成分 |
JP2005225841A (ja) * | 2004-02-16 | 2005-08-25 | Snow Brand Milk Prod Co Ltd | 病原体感染防御剤 |
ITRM20040166A1 (it) | 2004-03-31 | 2004-06-30 | Alberto Cresci | Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi. |
US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
WO2006012536A2 (en) * | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
WO2006093022A1 (ja) | 2005-03-03 | 2006-09-08 | Meiji Dairies Corporation | 免疫機能調整剤 |
ES2382873T3 (es) * | 2005-04-26 | 2012-06-14 | Teagasc, The Agriculture And Food Development Authority | Composición probiótica adecuada para animales |
ES2277550B1 (es) * | 2005-12-21 | 2008-06-16 | Laboratorios Casen-Fleet, S.L. | Kit farmaceutico para la preparacion de una sal de hidratacion con un probiotico para bebes. |
AU2007225549B2 (en) * | 2006-03-10 | 2012-09-27 | N.V. Nutricia | Use of non-digestable sacharides for giving an infant the best start after birth |
KR101355770B1 (ko) * | 2006-05-31 | 2014-02-03 | 가부시키가이샤 메이지 | 면역조절 활성이 높은 유산균의 배양법 |
DK2046943T3 (da) | 2006-08-04 | 2013-09-23 | Bioneer Corp | Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt |
JP2008074768A (ja) * | 2006-09-21 | 2008-04-03 | Yumex Biotech Co Ltd | 宿主特異的プロバイオティクス製品 |
WO2008106372A1 (en) * | 2007-02-28 | 2008-09-04 | Mead Johnson Nutrition Company | Method for treating or preventing systemic inflammation |
DK1992351T3 (en) * | 2007-05-18 | 2016-06-06 | Nestec Sa | Lactobacillus johnsonii for the prevention of post-surgical infection |
EP1997880A1 (de) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Bifidobakterien aus der Muttermilch, Verbindungen davon, deren Verwendung und Kulturmedium zu deren Gewinnung |
EP1997499A1 (de) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mikroorganismen aus der Muttermilch, Zusammensetzungen, die diese enthalten und deren Verwendung zur Behandlung von Mastitis |
PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
KR100886793B1 (ko) * | 2007-06-26 | 2009-03-04 | 한경대학교 산학협력단 | 항균과 생균 활성을 가지는 신규한락토바실러스 코르니포미스 hd-02 균주 및 이의 용도 |
JP5189906B2 (ja) * | 2007-09-14 | 2013-04-24 | 国立大学法人群馬大学 | 菌の異常集積検出方法および装置、並びに菌異常集積検出の警告スコア累積のグラフ化方法および装置 |
US20110223248A1 (en) * | 2007-12-12 | 2011-09-15 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
US20110189148A1 (en) * | 2008-06-25 | 2011-08-04 | Ritter Pharmaceuticals, Inc. | Lactose compositions with decreased lactose content |
MX2011005490A (es) * | 2008-12-05 | 2011-06-20 | Nestec Sa | Composiciones para usarse en niños con peso de nacimiento bajo. |
CA2984935C (en) * | 2009-02-24 | 2021-01-12 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
KR101087973B1 (ko) * | 2009-06-30 | 2011-12-01 | 일동제약주식회사 | 신규한 락토바실루스 헬베티쿠스, 이의 배양 방법 및 용도 |
BG110506A (bg) | 2009-10-27 | 2011-05-31 | "Селур Вк Холдинг" Еоод | Нови щамове млечно-кисели бактерии и техни комбинации за получаване на пробиотични препарати |
US9492487B2 (en) * | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
EP3202406A1 (de) * | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und deren verwendungen |
WO2012031186A1 (en) | 2010-09-03 | 2012-03-08 | Wisconsin Pharmacal Company, Llc. | Prebiotic suppositories |
CL2010001124A1 (es) * | 2010-10-14 | 2011-01-21 | Univ De Concepcion 50% Ma Loreto Ormeno 50% | Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia. |
EP2449890A1 (de) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Getreidepulverzusammensetzungen mit nicht-replizierenden probiotischen Mikroorganismen |
JP5840368B2 (ja) | 2011-02-02 | 2016-01-06 | カルピス株式会社 | 関節炎予防改善用物質 |
US10039296B2 (en) | 2011-06-20 | 2018-08-07 | H.J. Heinz Company Brands Llc | Probiotic compositions and methods |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
US20130089638A1 (en) * | 2011-10-11 | 2013-04-11 | Mead Johnson Nutrition Company | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
PT2861242T (pt) | 2012-06-18 | 2018-11-07 | Heinz Co Brands H J Llc | Disfunções relacionadas com o glúten |
JP2012184261A (ja) * | 2012-06-21 | 2012-09-27 | Snow Brand Milk Products Co Ltd | 免疫増強剤 |
CA2890507A1 (en) * | 2012-11-16 | 2014-05-22 | Calpis Co., Ltd. | Agent for alleviating stress-induced bowel disorder containing specific lactobacillus gasseri strain or treated product threof |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
JP5927730B2 (ja) * | 2013-04-11 | 2016-06-01 | アサヒグループホールディングス株式会社 | 免疫調節作用を有する乳酸菌のスクリーニング方法 |
CA2911496C (en) | 2013-05-10 | 2023-08-22 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
EP2818056A1 (de) | 2013-06-25 | 2014-12-31 | Biosearch S.A. | Probiotische Bakterien mit Metallen, Metallnanopartikel und Verwendungen davon |
WO2015093937A1 (en) * | 2013-12-19 | 2015-06-25 | N.V. Nutricia | Lactobacillus salivarius for the treatment of mastitis |
EP3395351A1 (de) | 2014-12-23 | 2018-10-31 | 4D Pharma Research Limited | Immunmodulation |
JP6427278B2 (ja) | 2014-12-23 | 2018-11-21 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | pirinポリペプチド及び免疫モジュレーション |
CN107847529B (zh) | 2015-06-15 | 2022-05-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
PT3650033T (pt) | 2015-06-15 | 2022-05-25 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
BR112017025005A2 (pt) | 2015-06-15 | 2018-08-07 | 4D Pharma Research Limited | composições compreendendo cepas baterianas |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
WO2017058175A1 (en) | 2015-09-29 | 2017-04-06 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
MA41013A (fr) | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EA035949B1 (ru) | 2016-03-04 | 2020-09-04 | 4Д ФАРМА ПиЭлСи | Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности |
TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
EP3485277A1 (de) * | 2016-07-18 | 2019-05-22 | Philippe Ulsemer | Natürliche mikroorganismen mit natürlicher fähigkeit zur bindung von toxinen und/oder toxinrezeptoren |
KR101873899B1 (ko) | 2016-08-09 | 2018-07-03 | 씨제이제일제당(주) | 락토바실러스 살리바리우스 cjls1511, 상기 균 또는 이의 사균체를 포함하는 동물 사료 첨가제 조성물, 및 상기 사균체의 제조 방법 |
TWI598103B (zh) * | 2016-08-22 | 2017-09-11 | 景岳生物科技股份有限公司 | 改善困難梭狀桿菌感染症狀的發酵乳酸桿菌gmnl-296組合物及方法 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN110234325A (zh) | 2017-02-28 | 2019-09-13 | 金伯利-克拉克环球有限公司 | 用于维护微生物群落的健康平衡的协同组合物 |
MA48939B1 (fr) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
HUE053488T2 (hu) | 2017-06-14 | 2021-06-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
MD3600364T2 (ro) | 2017-06-14 | 2020-12-31 | 4D Pharma Res Ltd | Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora |
LT3638271T (lt) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterines padermes |
IT201700068009A1 (it) * | 2017-06-19 | 2018-12-19 | Probiotical Spa | Composizione comprendente ceppi di batteri appartenenti alla specie Lactobacillus salivarius per il trattamento del morbo di Parkinson |
WO2020033440A1 (en) * | 2018-08-10 | 2020-02-13 | The Regents Of The University Of California | Methods and compositions for treating and preventing inflammatory diseases |
CN109161496A (zh) * | 2018-08-19 | 2019-01-08 | 东北农业大学 | 鼠李糖乳杆菌高密度菌液及其包埋菌粉的制备方法 |
KR101995328B1 (ko) * | 2018-12-10 | 2019-07-02 | 한국식품연구원 | 항암 활성을 갖는 락토바실러스 퍼멘텀 WiKim0102 및 이를 유효성분으로 포함하는 조성물 |
AU2019396990A1 (en) * | 2018-12-10 | 2021-07-22 | Korea Food Research Institute | Lactobacillus fermentum WiKim0102 having anticancer activity and composition comprising same as effective component |
EP3958690A4 (de) * | 2019-05-31 | 2023-04-19 | South Dakota Board of Regents | Probiotika zur hemmung von enterischen pathogenen |
CN110075054A (zh) * | 2019-06-06 | 2019-08-02 | 山东天源人乳库科技发展有限公司 | 一种来源于人乳的人源性生长因子修复制剂及其制备方法 |
TWI744028B (zh) * | 2019-10-07 | 2021-10-21 | 大江生醫股份有限公司 | 促進丁酸菌生長之益生質組合物及其用途 |
CN114761029A (zh) | 2019-11-29 | 2022-07-15 | 雀巢产品有限公司 | 用于预防或治疗乳腺炎的具有益生菌和n-3脂肪酸的组合物和方法 |
US20220409679A1 (en) | 2019-11-29 | 2022-12-29 | Societe Des Produits Nestle S.A. | Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis |
EP4121073B1 (de) | 2020-03-16 | 2024-07-03 | Biosearch S.A. | Biokomposite mit probiotika, kollagen und bakteriellem extrazellulärem polysaccharid und verwendungen davon |
DE202021105157U1 (de) | 2021-09-24 | 2021-10-13 | Reiner Rittinghausen | Zusammensetzung zur nutritiven Ergänzung bei Infektanfälligkeit und geschwächtem Immunsystem |
CN114437969B (zh) * | 2022-01-24 | 2024-05-14 | 美益添生物医药(武汉)有限公司 | 一种嗜酸乳杆菌md-286及其应用 |
BR102023006892A2 (pt) | 2022-04-13 | 2023-10-24 | Bluestone Pharma Gmbh | Produto compreendendo probióticos e isomaltulose e método de sua produção |
WO2023198814A1 (en) | 2022-04-13 | 2023-10-19 | Bluestone Pharma Gmbh | Compressed product comprising probiotics and method for its production |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE161181T1 (de) | 1992-07-06 | 1998-01-15 | Nestle Sa | Lactobacillus acidophilus enthaltende antigastritis-mittel |
DE69219768T2 (de) | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
US6107033A (en) * | 1995-07-28 | 2000-08-22 | Rijksuniversiteit Groningen | Methods and materials for determining relative abundance of microorganisms in mixed populations |
EP1034787A1 (de) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen |
-
2003
- 2003-06-26 AU AU2003242763A patent/AU2003242763B2/en not_active Expired
- 2003-06-26 CA CA2490016A patent/CA2490016C/en not_active Expired - Lifetime
- 2003-06-26 EP EP03761516A patent/EP1565547B2/de not_active Expired - Lifetime
- 2003-06-26 WO PCT/EP2003/006752 patent/WO2004003235A2/en active IP Right Grant
- 2003-06-26 AT AT03761516T patent/ATE402993T1/de active
- 2003-06-26 US US10/609,195 patent/US20040057943A1/en not_active Abandoned
- 2003-06-26 JP JP2004516689A patent/JP4176715B2/ja not_active Expired - Lifetime
- 2003-06-26 DE DE60322570T patent/DE60322570D1/de not_active Expired - Lifetime
- 2003-06-26 PT PT03761516T patent/PT1565547E/pt unknown
- 2003-06-26 ES ES03761516T patent/ES2311729T5/es not_active Expired - Lifetime
- 2003-06-26 DK DK03761516.8T patent/DK1565547T4/da active
- 2003-06-26 SI SI200331378T patent/SI1565547T2/sl unknown
- 2003-06-26 NZ NZ537706A patent/NZ537706A/en not_active IP Right Cessation
-
2004
- 2004-12-28 US US11/024,370 patent/US7468270B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004003235A2 (en) | 2004-01-08 |
JP4176715B2 (ja) | 2008-11-05 |
US7468270B2 (en) | 2008-12-23 |
AU2003242763B2 (en) | 2008-02-21 |
NZ537706A (en) | 2008-03-28 |
CA2490016C (en) | 2017-08-22 |
WO2004003235A3 (en) | 2004-06-10 |
AU2003242763A1 (en) | 2004-01-19 |
ES2311729T3 (es) | 2009-02-16 |
PT1565547E (pt) | 2008-11-03 |
SI1565547T1 (sl) | 2008-12-31 |
US20040057943A1 (en) | 2004-03-25 |
ATE402993T1 (de) | 2008-08-15 |
ES2311729T5 (es) | 2013-02-14 |
EP1565547B2 (de) | 2012-09-19 |
US20050244392A1 (en) | 2005-11-03 |
DK1565547T4 (da) | 2013-01-14 |
CA2490016A1 (en) | 2004-01-08 |
EP1565547A2 (de) | 2005-08-24 |
EP1565547B1 (de) | 2008-07-30 |
JP2005536197A (ja) | 2005-12-02 |
SI1565547T2 (sl) | 2013-02-28 |
DK1565547T3 (da) | 2008-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60322570D1 (de) | Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung | |
JP7387587B2 (ja) | クロストリジウム・ディフィシル感染症の治療における新たな使用 | |
Rai et al. | Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension | |
MX2022003374A (es) | Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales. | |
Maragkoudakis et al. | Probiotic potential of Lactobacillus strains isolated from dairy products | |
MX2022003372A (es) | Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales. | |
Vemuri et al. | Role of lactic acid probiotic bacteria in IBD | |
TR200101699T2 (tr) | Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması | |
WO2000071138A3 (en) | Oral administration of lactobacillus for the maintenance of health in women | |
BR0116349A (pt) | Compostos probióticos derivados da cepa ke01 de lactobacillus casei | |
ATE409220T1 (de) | Lactobacillus-stämme | |
EA200701992A1 (ru) | Смесь по меньшей мере из 6 видов молочнокислых бактерий и/или бифидобактерий в производстве закваски | |
AR042313A1 (es) | Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal | |
ITMI20131473A1 (it) | Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale | |
IT201600083376A1 (it) | Uso di probiotici per aumentare l’assorbimento proteico | |
JP2008539776A5 (de) | ||
Vemuri et al. | Probiotics: a novel approach in improving the values of human life | |
Vankerckhoven et al. | Establishment of the PROSAFE collection of probiotic and human lactic acid bacteria | |
Michaylova et al. | Probiotic candidates among dairy Lactobacilli and Streptococcus thermophiles strains for control of the oral pathogen Porphyromonas gingivalis | |
Kabiri et al. | Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study. | |
Yang et al. | Isolation of probiotic piliated lactobacillus rhamnosus strains from human fecal microbiota using SPaA antiserum-based colony immunoblotting | |
Zambori et al. | The antimicrobial role of probiotics in the oral cavity in humans and dogs | |
TWI406665B (zh) | 益生菌株gm-080用於製備治療心臟發炎與心臟細胞凋亡之醫藥組合物及其用途 | |
RU2010153265A (ru) | Способ уменьшения урчания в животе путем введения бактерий рода bifidobacterium | |
RU2008102619A (ru) | ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
R102 | Epo decision maintaining patent in amended form now final |
Ref document number: 1565547 Country of ref document: EP Effective date: 20120919 |